Stocks / NASDAQ / Immunocore Holdings plc

Immunocore Holdings plc

Our Opinion

Immunocore Holdings plc is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Care and Ethical Treatment of Animals in Research” (Page 1) Read the full document

Company Description

Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune.

Company Website: